Millennium Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-585,406
| Closed | -$1.99M | – | 4461 |
|
|
2018
Q3 | $1.99M | Sell |
585,406
-141,718
| -19% | -$511K | ﹤0.01% | 2446 |
|
|
2018
Q2 | $2.73M | Sell |
727,124
-213,465
| -23% | -$1.04M | ﹤0.01% | 2198 |
|
|
2018
Q1 | $3.85M | Buy |
+940,589
| New | +$4.38M | 0.01% | 1960 |
|
|
2017
Q4 | – | Sell |
-1,444,625
| Closed | -$10.3M | – | 4264 |
|
|
2017
Q3 | $10.3M | Sell |
1,444,625
-411,214
| -22% | -$2.96M | 0.02% | 1224 |
|
|
2017
Q2 | $13.4M | Buy |
1,855,839
+581,419
| +46% | +$3.63M | 0.02% | 888 |
|
|
2017
Q1 | $7.85M | Buy |
1,274,420
+417,186
| +49% | +$2.29M | 0.01% | 1168 |
|
|
2016
Q4 | $5.02M | Buy |
857,234
+599,504
| +233% | +$3.28M | 0.01% | 1327 |
|
|
2016
Q3 | $1.37M | Sell |
257,730
-713,074
| -73% | -$3.84M | ﹤0.01% | 2122 |
|
|
2016
Q2 | $6.43M | Buy |
970,804
+661,757
| +214% | +$3.7M | 0.01% | 1112 |
|
|
2016
Q1 | $1.44M | Sell |
309,047
-632,287
| -67% | -$2.52M | ﹤0.01% | 1981 |
|
|
2015
Q4 | $4.75M | Buy |
941,334
+901,827
| +2,283% | +$4.28M | 0.01% | 1394 |
|
|
2015
Q3 | $139K | Sell |
39,507
-601,941
| -94% | -$4.03M | ﹤0.01% | 3211 |
|
|
2015
Q2 | $6.4M | Buy |
641,448
+425,646
| +197% | +$4.56M | 0.01% | 1231 |
|
|
2015
Q1 | $2.75M | Buy |
215,802
+150,461
| +230% | +$1.93M | 0.01% | 1760 |
|
|
2014
Q4 | $925K | Buy |
+65,341
| New | +$1.01M | ﹤0.01% | 2543 |
|
|
2014
Q3 | – | Sell |
-39,565
| Closed | -$609K | – | 4170 |
|
|
2014
Q2 | $609K | Buy |
39,565
+20,509
| +108% | +$291K | ﹤0.01% | 2479 |
|
|
2014
Q1 | $325K | Sell |
19,056
-208,614
| -92% | -$3.15M | ﹤0.01% | 2889 |
|
|
2013
Q4 | $2.95M | Sell |
227,670
-152,693
| -40% | -$1.82M | 0.01% | 1538 |
|
|
2013
Q3 | $3.84M | Sell |
380,363
-735,651
| -66% | -$6.55M | 0.01% | 1270 |
|
|
2013
Q2 | $8.34M | Buy |
+1,116,014
| New | +$8.72M | 0.03% | 722 |
|
Millennium Management's KERX Position: Q4 2018 in Review
Millennium Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 585,406 shares — an estimated $1.99M sold.
Millennium Management first reported a position in KERX in Q2 2013 and held it in 20 quarters. The position peaked at $13.4M in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Millennium Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Millennium Management sold 585,406 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $1.99M.
- Millennium Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
- Millennium Management's Keryx Biopharmaceuticals Inc position peaked at $13.4M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.